Share Price, page-8048

NNZ2591 I believe is going to be the best thing since sliced bread for many acute conditions. Our management team have been very focused on this for many years and my bet is that in next few weeks we will finally start to see the true value of the business.

If management weren’t confident in the science, they would have let the business go for around the $20.00 - $25.00 mark, but, no, they are confident that further development of the product will generate multiple interest from big Pharma. Can anyone imagine if this had positive outcomes for Autism. The share price would be so God dam large, the biggest Pharma would have to join forces to buy us.

Management should be commended for the tightest of tightest confidentiality as there never seems to be a leak.

I assume all biotech analysts are waiting with bated breath for these results, to then start putting some numbers together. Most Pharma are a one trick pony, we are hopefully a merry go round, with pony after pony, helping the much needed.

Imagine how many Katelins we can help as a company and imagine if all the stars align and we can develop this science to multiple positive outcomes.

Fingers and toes crossed for a big set of successful results.